Innealta Capital’s Hims & Hers Health HIMS Stock Holding History

Innealta Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-94	Closed	-$1.9K	–	821
2024 Q2	$1.9K	Buy	+94	New	+$1.56K	﹤0.01%	1110

Other funds holding HIMS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IVMX

Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Innealta Capital's HIMS Position: Q3 2024 in Review

Innealta Capital sold out of Hims & Hers Health (HIMS) in Q3 2024, closing a stake of 94 shares — an estimated $1.9K sold.

Innealta Capital first reported a position in HIMS in Q2 2024 and held it in 1 quarter. The position peaked at $1.9K in Q2 2024. 308 funds tracked by Wall St. Rank hold HIMS as of Q3 2024.

Innealta Capital reported no remaining Hims & Hers Health position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 94 Hims & Hers Health shares in Q3 2024, an estimated $1.9K.
Innealta Capital first reported a position in Hims & Hers Health in Q2 2024 and held it in 1 quarter.
Innealta Capital's Hims & Hers Health position peaked at $1.9K in Q2 2024.
308 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.